- ClearPoint Neuro is both a medical device and a biologics & drug delivery company. Both opportunities leverage a common navigation system with superior advantages over existing solutions.
- New product developments in the pipeline allow them to penetrate into 90% of the operating room surgeries which they are not in today.
- With a target to be in 100 centers conducting 100 cases each, 30 biologics & drug delivery partners, we believe the business to be worth at least $600M by 2025.
For further details see:
ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company